World Federation of Hemophilia Gene Therapy Registry

被引:36
作者
Konkle, Barbara A. [1 ]
Coffin, Donna [2 ]
Pierce, Glenn F. [2 ]
Clark, Cary [3 ]
George, Lindsey [4 ,5 ]
Iorio, Alfonso [6 ]
Mahlangu, Johnny [3 ,7 ,8 ]
Naccache, Mayss [2 ]
O'Mahony, Brian [9 ,10 ]
Peyvandi, Flora [3 ,11 ,12 ]
Pipe, Steve [13 ,14 ]
Quartel, Adrian
Sawyer, Eileen K. [16 ]
Skinner, Mark W. [15 ,17 ]
Tortella, Bartholomew [18 ]
Watson, Crystal [19 ]
Winburn, Ian [20 ]
机构
[1] Washington Ctr Bleeding Disorders, Bloodworks NW, Seattle, WA USA
[2] World Federat Hemophilia, Montreal, PQ, Canada
[3] Int Soc Thrombosis & Hemostasis, Carrboro, NC USA
[4] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] McMaster Univ, Hamilton, ON, Canada
[7] Univ Witwatersrand, Haemophilia Comprehens Care Ctr, NHLS, Johannesburg, South Africa
[8] Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa
[9] Irish Haemophilia Soc, Dublin, Ireland
[10] European Hemophilia Consortium, Brussels, Belgium
[11] IRCCS Maggiore Hosp Milan, Milan, Italy
[12] Univ Milan, Milan, Italy
[13] Univ Michigan, Pediat, Ann Arbor, MI USA
[14] Natl Hemophilia Fdn, New York, NY USA
[15] BioMarin Pharmaceut Inc, Novato, CA USA
[16] UniQure Inc, Lexington, KY USA
[17] Inst Policy Adv Ltd, Washington, DC USA
[18] Spark Therapeut Inc, Philadelphia, PA USA
[19] Amer Thrombosis & Hemostssasis Network, Chicago, IL USA
[20] Pfizer Inc, New York, NY USA
关键词
HUMAN FACTOR-VIII; MOLECULAR-CLONING;
D O I
10.1111/hae.14015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:563 / 564
页数:2
相关论文
共 17 条
[1]  
[Anonymous], 2020, HEM GEN THER PHAS 3
[2]   THE GENE STRUCTURE OF HUMAN ANTI-HEMOPHILIC FACTOR-IX [J].
ANSON, DS ;
CHOO, KH ;
REES, DJG ;
GIANNELLI, F ;
GOULD, K ;
HUDDLESTON, JA ;
BROWNLEE, GG .
EMBO JOURNAL, 1984, 3 (05) :1053-1060
[3]  
Butterfield JSS, 2019, MOL THER, VS1525-0016, P30502
[4]   MOLECULAR-CLONING OF THE GENE FOR HUMAN ANTI-HEMOPHILIC FACTOR-IX [J].
CHOO, KH ;
GOULD, KG ;
REES, DJG ;
BROWNLEE, GG .
NATURE, 1982, 299 (5879) :178-180
[5]   Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year [J].
George, Lindsey A. ;
Sullivan, Spencer K. ;
Rasko, John E. J. ;
Giermasz, Adam ;
Samelson-Jones, Benjamin J. ;
Ducore, Jonathan M. ;
Teitel, Jerome M. ;
McGuinn, Catherine E. ;
Runowski, Alexa R. ;
Wright, Fraser ;
Anguela, Xavier M. ;
High, Katherine A. ;
Rybin, Denis ;
Murphy, John E. ;
Rupon, Jeremy .
BLOOD, 2019, 134
[6]   CHARACTERIZATION OF THE HUMAN FACTOR-VIII GENE [J].
GITSCHIER, J ;
WOOD, WI ;
GORALKA, TM ;
WION, KL ;
CHEN, EY ;
EATON, DH ;
VEHAR, GA ;
CAPON, DJ ;
LAWN, RM .
NATURE, 1984, 312 (5992) :326-330
[7]   Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B [J].
Nathwani, A. C. ;
Reiss, U. M. ;
Tuddenham, E. G. D. ;
Rosales, C. ;
Chowdary, P. ;
McIntosh, J. ;
Della Peruta, M. ;
Lheriteau, E. ;
Patel, N. ;
Raj, D. ;
Riddell, A. ;
Pie, J. ;
Rangarajan, S. ;
Bevan, D. ;
Recht, M. ;
Shen, Y. -M. ;
Halka, K. G. ;
Basner-Tschakarjan, E. ;
Mingozzi, F. ;
High, K. A. ;
Allay, J. ;
Kay, M. A. ;
Ng, C. Y. C. ;
Zhou, J. ;
Cancio, M. ;
Morton, C. L. ;
Gray, J. T. ;
Srivastava, D. ;
Nienhuis, A. W. ;
Davidoff, A. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (21) :1994-2004
[8]  
Nathwani AC, 2019, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/hematology.2019000007
[9]   Long-Term AAV-Mediated Factor VIII Expression in Nine Hemophilia A Dogs: A 10 Year Follow-up Analysis on Durability, Safety and Vector Integration [J].
Nguyen, Giang N. ;
Everett, John K. ;
Raymond, Hayley ;
Kafle, Samita ;
Merricks, Elizabeth P. ;
Kazazian, Haig H. ;
Nichols, Timothy C. ;
Bushman, Frederic D. ;
Sabatino, Denise E. .
BLOOD, 2019, 134
[10]   Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A [J].
Pasi, K. John ;
Rangarajan, Savita ;
Mitchell, Nina ;
Lester, Will ;
Symington, Emily ;
Madan, Bella ;
Laffan, Michael ;
Russell, Chris B. ;
Li, Mingjin ;
Pierce, Glenn F. ;
Wong, Wing Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) :29-40